Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Shares Issued (2018 - 2025)

Serina Therapeutics' Shares Issued history spans 7 years, with the latest figure at -$2000.0 for Q3 2025.

  • For Q3 2025, Shares Issued fell 100.04% year-over-year to -$2000.0; the TTM value through Jun 2025 reached $5.0 million, up 166100.0%, while the annual FY2024 figure was $5.0 million, N/A changed from the prior year.
  • Shares Issued for Q3 2025 was -$2000.0 at Serina Therapeutics, down from $1000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $5.0 million in Q3 2024 and bottomed at -$2000.0 in Q3 2025.
  • The 4-year median for Shares Issued is $1000.0 (2025), against an average of $783285.7.
  • The largest annual shift saw Shares Issued skyrocketed 498500.0% in 2024 before it plummeted 100.04% in 2025.
  • A 4-year view of Shares Issued shows it stood at $496000.0 in 2021, then crashed by 100.2% to -$1000.0 in 2023, then surged by 498500.0% to $5.0 million in 2024, then tumbled by 100.04% to -$2000.0 in 2025.
  • Per Business Quant, the three most recent readings for SER's Shares Issued are -$2000.0 (Q3 2025), $1000.0 (Q2 2025), and $1000.0 (Q1 2025).